Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuzo Sugita is active.

Publication


Featured researches published by Shuzo Sugita.


The EMBO Journal | 1999

A conformational switch in syntaxin during exocytosis: role of munc18

Irina Dulubova; Shuzo Sugita; Sandra Hill; Masahiro Hosaka; Imma Fernandez; Thomas C. Südhof; Josep Rizo

Syntaxin 1, an essential protein in synaptic membrane fusion, contains a helical autonomously folded N‐terminal domain, a C‐terminal SNARE motif and a transmembrane region. The SNARE motif binds to synaptobrevin and SNAP‐25 to assemble the core complex, whereas almost the entire cytoplasmic sequence participates in a complex with munc18‐1, a neuronal Sec1 homolog. We now demonstrate by NMR spectroscopy that, in isolation, syntaxin adopts a ‘closed’ conformation. This default conformation of syntaxin is incompatible with core complex assembly which requires an ‘open’ syntaxin conformation. Using site‐directed mutagenesis, we find that disruption of the closed conformation abolishes the ability of syntaxin to bind to munc18‐1 and to inhibit secretion in PC12 cells. These results indicate that syntaxin binds to munc18‐1 in a closed conformation and suggest that this conformation represents an essential intermediate in exocytosis. Our data suggest a model whereby, during exocytosis, syntaxin undergoes a large conformational switch that mediates the transition between the syntaxin–munc18‐1 complex and the core complex.


Journal of Cell Biology | 2001

A stoichiometric complex of neurexins and dystroglycan in brain

Shuzo Sugita; Fumiaki Saito; Jiong Tang; Jakob S. Satz; Kevin P. Campbell; Thomas C. Südhof

In nonneuronal cells, the cell surface protein dystroglycan links the intracellular cytoskeleton (via dystrophin or utrophin) to the extracellular matrix (via laminin, agrin, or perlecan). Impairment of this linkage is instrumental in the pathogenesis of muscular dystrophies. In brain, dystroglycan and dystrophin are expressed on neurons and astrocytes, and some muscular dystrophies cause cognitive dysfunction; however, no extracellular binding partner for neuronal dystroglycan is known. Regular components of the extracellular matrix, such as laminin, agrin, and perlecan, are not abundant in brain except in the perivascular space that is contacted by astrocytes but not by neurons, suggesting that other ligands for neuronal dystroglycan must exist. We have now identified α- and β-neurexins, polymorphic neuron-specific cell surface proteins, as neuronal dystroglycan receptors. The extracellular sequences of α- and β-neurexins are largely composed of laminin-neurexin–sex hormone–binding globulin (LNS)/laminin G domains, which are also found in laminin, agrin, and perlecan, that are dystroglycan ligands. Dystroglycan binds specifically to a subset of the LNS domains of neurexins in a tight interaction that requires glycosylation of dystroglycan and is regulated by alternative splicing of neurexins. Neurexins are receptors for the excitatory neurotoxin α-latrotoxin; this toxin competes with dystroglycan for binding, suggesting overlapping binding sites on neurexins for dystroglycan and α-latrotoxin. Our data indicate that dystroglycan is a physiological ligand for neurexins and that neurexins tightly regulated interaction could mediate cell adhesion between brain cells.


Neuron | 2001

Synaptotagmin VII as a Plasma Membrane Ca2+ Sensor in Exocytosis

Shuzo Sugita; Weiping Han; Stefan Butz; Xinran Liu; Rafael Fernández-Chacón; Ye Lao; Thomas C. Südhof

Synaptotagmins I and II are Ca(2+) binding proteins of synaptic vesicles essential for fast Ca(2+)-triggered neurotransmitter release. However, central synapses and neuroendocrine cells lacking these synaptotagmins still exhibit Ca(2+)-evoked exocytosis. We now propose that synaptotagmin VII functions as a plasma membrane Ca(2+) sensor in synaptic exocytosis complementary to vesicular synaptotagmins. We show that alternatively spliced forms of synaptotagmin VII are expressed in a developmentally regulated pattern in brain and are concentrated in presynaptic active zones of central synapses. In neuroendocrine PC12 cells, the C(2)A and C(2)B domains of synaptotagmin VII are potent inhibitors of Ca(2+)-dependent exocytosis, but only when they bind Ca(2+). Our data suggest that in synaptic vesicle exocytosis, distinct synaptotagmins function as independent Ca(2+) sensors on the two fusion partners, the plasma membrane (synaptotagmin VII) versus synaptic vesicles (synaptotagmins I and II).


Journal of Biological Chemistry | 1998

α-Latrotoxin Receptor CIRL/Latrophilin 1 (CL1) Defines an Unusual Family of Ubiquitous G-protein-linked Receptors G-PROTEIN COUPLING NOT REQUIRED FOR TRIGGERING EXOCYTOSIS

Shuzo Sugita; Konstantin Ichtchenko; Mikhail Khvotchev; Thomas C. Südhof

α-Latrotoxin, a potent excitatory neurotoxin, binds to two receptors: a G-protein-coupled receptor calledCIRL/latrophilin 1 (CL1) and a cell-surface protein called neurexin Iα. We now show that CL1 belongs to a family of closely related receptors called CL1, CL2, and CL3. CLs exhibit an unusual multidomain structure with similar alternative splicing and large extra- and intracellular sequences. CLs share domains with other G-protein-coupled receptors, lectins, and olfactomedins/myocilin. In addition, CLs contain a novel, widespread cysteine-rich domain that may direct endoproteolytic processing of CLs during transport to the cell surface. Although the mRNAs for CLs are enriched in brain, CLs are ubiquitously expressed in all tissues. To examine how binding of α-latrotoxin to CL1 triggers exocytosis, we used PC12 cells transfected with human growth hormone. Ca2+-dependent secretion of human growth hormone from transfected PC12 cells was triggered by KCl depolarization or α-latrotoxin and was inhibited by tetanus toxin and by phenylarsine oxide, a phosphoinositide kinase inhibitor. When CL1 was transfected into PC12 cells, their response to α-latrotoxin was sensitized dramatically. A similar sensitization to α-latrotoxin was observed with different splice variants of CL1, whereas CL2 and CL3 were inactive in this assay. A truncated form of CL1 that contains only a single transmembrane region and presumably is unable to mediate G-protein-signaling was as active as wild type CL1 in α-latrotoxin-triggered exocytosis. Our data show that CL1, CL2, and CL3 perform a general and ubiquitous function as G-protein-coupled receptors in cellular signaling. In addition, CL1 serves a specialized role as an α-latrotoxin receptor that does not require G-protein-signaling for triggering exocytosis. This suggests that as an α-latrotoxin receptor, CL1 recruits α-latrotoxin to target membranes without participating in exocytosis directly.


Neuron | 2003

Sr2+ binding to the Ca2+ binding site of the synaptotagmin 1 C2B domain triggers fast exocytosis without stimulating SNARE interactions

Ok Ho Shin; Jeong-Seop Rhee; Jiong Tang; Shuzo Sugita; Christian Rosenmund; Thomas C. Südhof

Sr(2+) triggers neurotransmitter release similar to Ca(2+), but less efficiently. We now show that in synaptotagmin 1 knockout mice, the fast component of both Ca(2+)- and Sr(2+)-induced release is selectively impaired, suggesting that both cations partly act by binding to synaptotagmin 1. Both the C(2)A and the C(2)B domain of synaptotagmin 1 bind Ca(2+) in phospholipid complexes, but only the C(2)B domain forms Sr(2+)/phospholipid complexes; therefore, Sr(2+) binding to the C(2)B domain is sufficient to trigger fast release, although with decreased efficacy. Ca(2+) induces binding of the synaptotagmin C(2) domains to SNARE proteins, whereas Sr(2+) even at high concentrations does not. Thus, triggering of the fast component of release by Sr(2+) as a Ca(2+) agonist involves the formation of synaptotagmin/phospholipid complexes, but does not require stimulated SNARE binding.


Neuron | 1999

Neurexins Are Functional α-Latrotoxin Receptors

Shuzo Sugita; Mikhail Khvochtev; Thomas C. Südhof

Abstract α-Latrotoxin is a potent neurotoxin that triggers synaptic exocytosis. Surprisingly, two distinct neuronal receptors for α-latrotoxin have been described: CIRL/latrophilin 1 (CL1) and neurexin-1α. α-Latrotoxin is thought to trigger exocytosis by binding to CL1, while the role of neurexin 1α is uncertain. Using PC12 cells, we now demonstrate that neurexins indeed function as α-latrotoxin receptors that are at least as potent as CL1. Both α- and β-neurexins represent autonomous α-latrotoxin receptors that are regulated by alternative splicing. Similar to CL1, truncated neurexins without intracellular sequences are fully active; therefore, neurexins and CL1 recruit α-latrotoxin but are not themselves involved in exocytosis. Thus, α-latrotoxin is unique among neurotoxins, because it utilizes two unrelated receptors, probably to amplify recruitment of α-latrotoxin to active sites.


Nature Structural & Molecular Biology | 2004

A conformational switch in the Piccolo C2A domain regulated by alternative splicing

Jesús García; Stefan H. Gerber; Shuzo Sugita; Thomas C. Südhof; Josep Rizo

C2 domains are widespread Ca2+-binding modules. The active zone protein Piccolo (also known as Aczonin) contains an unusual C2A domain that exhibits a low affinity for Ca2+, a Ca2+-induced conformational change and Ca2+-dependent dimerization. We show here that removal of a nine-residue sequence by alternative splicing increases the Ca2+ affinity, abolishes the conformational change and abrogates dimerization of the Piccolo C2A domain. The NMR structure of the Ca2+-free long variant provides a structural basis for these different properties of the two splice forms, showing that the nine-residue sequence forms a β-strand otherwise occupied by a nonspliced sequence. Consequently, Ca2+-binding to the long Piccolo C2A domain requires a marked rearrangement of secondary structure that cannot occur for the short variant. These results reveal a novel mechanism of action of C2 domains and uncover a structural principle that may underlie the alteration of protein function by short alternatively spliced sequences.


The EMBO Journal | 1998

alpha-Latrotoxin action probed with recombinant toxin: receptors recruit alpha-latrotoxin but do not transduce an exocytotic signal

Konstantin Ichtchenko; Mikhail Khvotchev; Nikita Kiyatkin; Lance Simpson; Shuzo Sugita; Thomas C. Südhof

α‐Latrotoxin stimulates neurotransmitter release probably by binding to two receptors, CIRL/latrophilin 1 (CL1) and neurexin Iα. We have now produced recombinant α‐latrotoxin (LtxWT) that is as active as native α‐latrotoxin in triggering synaptic release of glutamate, GABA and norepinephrine. We have also generated three α‐latrotoxin mutants with substitutions in conserved cysteine residues, and a fourth mutant with a four‐residue insertion. All four α‐latrotoxin mutants were found to be unable to trigger release. Interestingly, the insertion mutant LtxN4C exhibited receptor‐binding affinities identical to wild‐type LtxWT, bound to CL1 and neurexin Iα as well as LtxWT, and similarly stimulated synaptic hydrolysis of phosphatidylinositolphosphates. Therefore, receptor binding by α‐latrotoxin and stimulation of phospholipase C are insufficient to trigger exocytosis. This conclusion was confirmed in experiments with La3+ and Cd2+. La3+ blocked release triggered by LtxWT, whereas Cd2+ enhanced it. Both cations, however, had no effect on the stimulation by LtxWT of phosphatidylinositolphosphate hydrolysis. Our data show that receptor binding by α‐latrotoxin and activation of phospholipase C do not by themselves trigger exocytosis. Thus receptors recruit α‐latrotoxin to its point of action without activating exocytosis. Exocytosis probably requires an additional receptor‐independent activity of α‐latrotoxin that is selectively inhibited by the LtxN4C mutation and by La3+.


Journal of Biological Chemistry | 1999

Synaptogyrins Regulate Ca2+-dependent Exocytosis in PC12 Cells

Shuzo Sugita; Roger Janz; Thomas C. Südhof

Synaptogyrins constitute a family of synaptic vesicle proteins of unknown function. With the full-length structure of a new brain synaptogyrin isoform, we now show that the synaptogyrin family in vertebrates includes two neuronal and one ubiquitous isoform. All of these synaptogyrins are composed of a short conserved N-terminal cytoplasmic sequence, four homologous transmembrane regions, and a variable cytoplasmic C-terminal tail that is tyrosine-phosphorylated. The localization, abundance, and conservation of synaptogyrins suggest a function in exocytosis. To test this, we employed a secretion assay in PC12 cells expressing transfected human growth hormone (hGH) as a reporter protein. When Ca2+-dependent hGH secretion from PC12 cells was triggered by high K+ or α-latrotoxin, co-transfection of all synaptogyrins with hGH inhibited hGH exocytosis as strongly as co-transfection of tetanus toxin light chain. Synaptophysin I, which is distantly related to synaptogyrins, was also inhibitory but less active. Inhibition was independent of the amount of hGH expressed but correlated with the amount of synaptogyrin transfected. Inhibition of exocytosis was not observed with several other synaptic proteins, suggesting specificity. Analysis of the regions of synaptogyrin required for inhibition revealed that the conserved N-terminal domain of synaptogyrin is essential for inhibition, whereas the long C-terminal cytoplasmic tail is largely dispensable. Our results suggest that synaptogyrins are conserved components of the exocytotic apparatus, which function as regulators of Ca2+-dependent exocytosis.


Journal of Biological Chemistry | 2006

Crystal Structure of the Second LNS/LG Domain from Neurexin 1α: Ca2+ BINDING AND THE EFFECTS OF ALTERNATIVE SPLICING*

Lauren R. Sheckler; Lisa Henry; Shuzo Sugita; Thomas C. Südhof; Gabby Rudenko

Neurexins mediate protein interactions at the synapse, playing an essential role in synaptic function. Extracellular domains of neurexins, and their fragments, bind a distinct profile of different proteins regulated by alternative splicing and Ca2+. The crystal structure of n1α_LNS#2 (the second LNS/LG domain of bovine neurexin 1α) reveals large structural differences compared with n1α_LNS#6 (or n1β_LNS), the only other LNS/LG domain for which a structure has been determined. The differences overlap the so-called hyper-variable surface, the putative protein interaction surface that is reshaped as a result of alternative splicing. A Ca2+-binding site is revealed at the center of the hyper-variable surface next to splice insertion sites. Isothermal titration calorimetry indicates that the Ca2+-binding site in n1α_LNS#2 has low affinity (Kd ∼ 400 μm). Ca2+ binding ceases to be measurable when an 8- or 15-residue splice insert is present at the splice site SS#2 indicating that alternative splicing can affect Ca2+-binding sites of neurexin LNS/LG domains. Our studies initiate a framework for the putative protein interaction sites of neurexin LNS/LG domains. This framework is essential to understand how incorporation of alternative splice inserts expands the information from a limited set of neurexin genes to produce a large array of synaptic adhesion molecules with potentially very different synaptic function.

Collaboration


Dive into the Shuzo Sugita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiong Tang

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Konstantin Ichtchenko

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mikhail Khvotchev

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Josep Rizo

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Fumiaki Saito

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Imma Fernandez

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Irina Dulubova

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jakob S. Satz

Howard Hughes Medical Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge